LONDON (AP) — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.
Walmsley, 56, will be replaced by Luke Miels, currently GSK’s chief commercial officer, the company said in a statement released on Monday.
While GSK achieved a number of strategic successes under Walmsley, including the spinoff of the consumer health care business Haleon, it has disappointed investors. GSK’s shares rose 3.3% to 1534.50 pence in early trading, making it the biggest gainer on the London Stock Exchange.
GSK’s shares fell 11% between April 1, 2017, when Walmsley became CEO, and last Friday.
“Despite the progress, the share price performance has been lackluster,” Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown,” said in a note to investors.
“Although her record of delivering on financial guidance has been strong, the company’s growth rates remain stuck in single-digit territory.”
Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
CEO of drugmaker GSK to step down by year’s end WHEC.com.
Hence then, the article about ceo of drugmaker gsk to step down by year s end was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CEO of drugmaker GSK to step down by year’s end )
Also on site :
- Route 59 in Naperville closed after Tesla crashes, bursts into flames
- San Luis Obispo Police make felony hit-and-run arrest
- Unsettling Court Documents Detail Allegations as Arrest Warrant Is Issued for ‘Little House on the Prairie’ Star Melissa Gilbert’s Husband